Association of 5-lipoxygenase gene polymorphisms with bronchial asthma

Experimental and Therapeutic Medicine

Volumn 4, Issue 6, 2012, Pages 967-971

  Bai, Chunying ^a   Yu, Xiaoming ^a   Yun, Rui ^a   Shi, Tiewei ^a   Zhang, Chaojun ^a   Zhou, Jing ^a   Sachurangui, ^b   Tong, Lijuan ^a   Li, Xiujun ^a   Gao, Lifeng ^a  

^a Chifeng University   (China)

^b Department of Pediatrics   (China)

Author keywords

5 lipoxygenase; Bronchial asthma; Single nucleotide polymorphism

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; GENOMIC DNA;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CHILD; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84867244190     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.712     Document Type: Article

References (19)

1. Sanak M: Genetic Variance of 5-lipoxygenase Metabolic Pathway in Bronchial Asthma. International Review of Asthma 4: 70-80, 2002.
2. Wong WS and Koh DS: Advances in immunopharmacology of asthma. Biochem Pharmacol 59: 1323-1335, 2000.
3. Chen XS, Sheller JR, Johnson EN and Funk CD: Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature 372: 179-182, 1994.
4. Samuelsson B: Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 220: 568-575, 1983.
5. Samuelsson B, Dahlén SE, Lindgren JA, Rouzer CA and Serhan CN: Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237: 1171-1176, 1987.
6. Lewis RA, Austen KF and Soberman RJ: Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N EngI J Med 323: 645-655, 1990.
7. Funk CD, Hoshiko S, Matsumoto T, Radmark O and Samuelsson B: Characterization of the human 5-lipoxygenase gene. Proc Natl Acad Sci USA 86: 2587-2591, 1989.
8. Drazen JM and Silverman ES: Genetic determinants of 5-lipoxygenase transcription. Int Arch Allergy Immunol 118: 275-278, 1999.
9. Silverman ES and Drazen JM: Genetic variations in the 5-lipoxygenase core promoter. Description and functional implications. Am J Respir Crit Care Med 161: S77-S80, 2000.
10. Bai C, Matsui E, Ohnishi H, et al: A novel polymorphism, E254K, in the 5-lipoxygenase gene associated with bronchial asthma. Int J Mol Med 21: 139-144, 2008.
11. Proceedings of the ATS workshop on refractory asthma. Am J Respir Crit Care Med 162, 2000.
12. Bai C, Zhou J, Rui Y, et al: Economical and Effective Method for Extract Blood Genomic DNA. Chinese journal of Laboratory Medicine and Clinic 7: 1795-1798, 2010.
13. Boyce JA, Broide D, Matsumoto K and Bochner BS: Advances in mechanisms of asthma, allergy, and immunology in 2008. J Allergy Clin Immunol 123: 569-574, 2009.
14. De Caterina R and Zampolli A: From asthma to atherosclerosis - 5-lipoxygenase, leukotrienes, and inflammation. New Eng J Med 350: 4-7, 2004.
15. In KH, Silverman ES, Asano K, Beier D, Fischer AR, Keith TP, et al: Mutations in the human 5-lipoxygenase gene. Clin Rev Allergy Immunol 17: 59-69, 1999.
16. van den Heuvel MM, Vanhee DD, Postmus PE, et al: Functional and phenotypic differences of monocyte-derived dendritic cells from allergic and nonallergic patients. Allergy Clin Immunol 101: 90-95, 1998.
17. Galli SJ: Complexity and reducdancy in the pathogenesis of asthma: reassessing the roles of mast cells and T cells. J Exp Med 186: 343-347, 1997.
18. Krouwels FH, Kerstens LC, van der Maarel HW, Degenhart HJ and Neijens HJ: Density of eosinophils reflects activity of disease in allergic asthmatic children. Clin Exp Allergy 25: 1171-1178, 1995.
19. Berretta F, Butler RH, Diaz G, Sanarico N, Arroyo J, Fraziano M, et al: Detailed analysis of the effects of Glu/Lys beta69 human leukocyte antigen-DP polymorphism on peptide-binding specificity. Tissue Antigens 62: 459-471, 2003.